Maynard Um
-
-
-
-
-
-
-
Canaccord Reiterates Buy Rating on Rani Therapeutics (RANI)
-
-
-
-
-
-
-
Rani Therapeutics Holdings, Inc. (RANI) Tops Q3 EPS by 5c
-
-
-
-
-
-
-
Rani Therapeutics (RANI) Announces Research Agreement with Chugai
-
-
-
-
-
-
-
Rani Therapeutics (RANI) Announces Preclinical Data Demonstrating Bioequivalence of RT-114
-
-
-
-
-
-
-
Rani Therapeutics Holdsing s (RANI) PT Lowered to $9 at H.C. Wainwright
-
-
-
466,315 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


